Basics Fennec Pharmaceuticals Inc. Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. IPO Date: September 11, 2017 Sector: Healthcare Industry: Biotech Market Cap: $257.86M Activated in VL: True Average Daily Range Avg Daily Range: $0.18 | 2.50% Avg Daily Range (30 D): $0.22 | 2.65% Avg Daily Range (90 D): $0.22 | 2.64% Institutional Daily Volume Avg Daily Volume: .09M Avg Daily Volume (30 D): .13M Avg Daily Volume (90 D): .08M Trade Size Avg Trade Size (Sh.): 124 Avg Trade Size (Sh.) (30 D): 98 Avg Trade Size (Sh.) (90 D): 90 Institutional Trades Total Inst.Trades: 37 Avg Inst. Trade: $2.78M Avg Inst. Trade (30 D): $1.22M Avg Inst. Trade (90 D): $1.22M Avg Inst. Trade Volume: .35M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.82M Avg Closing Trade (30 D): $1.22M Avg Closing Trade (90 D): $1.22M Avg Closing Volume: 709.79K     News Nov 14, 2025 @ 4:11 AM Fennec Pharmaceuticals Announces Private Offering ... Source: Fennec Pharmaceuticals Inc. Nov 14, 2025 @ 4:07 AM Fennec Pharmaceuticals Announces Pricing of Offeri... Source: Fennec Pharmaceuticals Inc. Aug 14, 2025 @ 3:04 PM Fennec Q2 Sales Jump 33 Percent Source: Na Jun 3, 2025 @ 8:31 PM Fennec Announces Results of Annual Meeting Source: N/A Feb 7, 2025 @ 12:00 PM Fennec Pharmaceuticals Announces Commercial Launch... Source: Fennec Pharmaceuticals Inc. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.02 $-.11 $-.04 Diluted EPS $-.02 $-.11 $-.04 Revenue $ 12.46M $ 9.65M $ 8.75M Gross Profit $ $ $ Net Income / Loss $ -.64M $ -3.15M $ -1.17M Operating Income / Loss $ -.19M $ -2.73M $ -.81M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio     Splits Sep 05, 2014:   1:3 Aug 30, 2011:   1:18 Aug 02, 2005:   1:5